Amass Brands (AMSS)
| Market Cap | $2.60M-98.7% |
| Revenue (ttm) | $17.74M |
| Net Income | -$20.19M |
| EPS | -$2.12 |
| Shares Out | 11.61M |
| PE Ratio | n/a |
| Forward PE | -0.23 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 460,357 |
| Open | $0.22 |
| Previous Close | $0.22 |
| Day's Range | $0.22 - $0.24 |
| 52-Week Range | $0.20 - $17.00 |
| Beta | n/a |
| Analysts | none |
| Price Target | $4.00(+1688.11%) |
| Earnings Date | n/a |
About AMSS
AMASS Brands, Inc. produces and sells botanical-based beverages, spirits, non-alcoholic drinks, and personal care products. The company provides botanical beverages, including spirits such as dry gin, botanic vodka, and limited edition spirits made with adaptogenic ingredients. It offers non-alcoholic beverages designed for social and self-care rituals, as well as personal care products that include candles, soaps, and hand sanitizers under the Midori Maison line. All products are made with natural, non-GMO botanical ingredients and do not contain artificial preservatives or unnecessary chemicals. The company emphasizes plant-based solutions for both everyday and celebratory occasions. The company was incorporated in 2016 and is based in Los Angeles, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
When insiders bought and sold
1 year · open-market trades only$AMSS stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in AMSS holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by AMSS's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
AMSS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
AMSS Revenue by Segment
| Cost of net revenues | $4.10M | 92.35% |
| Impairment loss | $339.28K | 7.65% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New AMSS patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to AMSS from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from AMSS’s recent data — informational, not investment advice
